PGEN- Precigen, Inc.

Name: Precigen, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Sabzevari Helen	3.77M	$18.17M	-119,250
Other	Lehr Donald P.	755.5K	$3.64M	-29,131
Dir	Turley James S	613.6K	$2.96M	-
CFO	Thomasian Harry Jr.	554.5K	$2.67M	-41,884
COO	Shah Rutul R	497.8K	$2.40M	-42,703

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 28, 2026	Tennant Phil	Chief Commercial Officer	Sell	30,272	$4.36	$131,985.92	-17.8%	-	-
May 28, 2026	Thomasian Harry Jr.56	Chief Financial Officer	Sell	41,884	$4.36	$182,614.24	-7.0%	-	-
May 28, 2026	Shah Rutul R60	Chief Operating Officer	Sell	42,703	$4.36	$186,185.08	-7.9%	-	-
May 28, 2026	Sabzevari Helen75	President And CEO	Sell	119,250	$4.36	$519,930.00	-3.1%	-	-
May 28, 2026	Lehr Donald P.75	Chief Legal Officer	Sell	29,131	$4.36	$127,011.16	-3.7%	-	-
Dec 22, 2025	Kirk Randal J	Director, 10% Owner	Sell	1,900,036	$4.18	$7,942,150.48	-1.9%	-26.0%	-
Dec 12, 2025	Kindler Jeffrey B71	Director	Sell	235,467	$3.63	$855,899.00	-68.0%	-11.1%	-
Nov 21, 2025	Kirk Randal J	Director, 10% Owner	Sell	2,966,293	$4.14	$12,291,748.11	-13.2%	+16.2%	-
Sep 30, 2025	Kirk Randal J	Director, 10% Owner	Sell	1,809,667	$3.41	$6,170,964.47	-11.0%	+35.3%	-
Sep 30, 2025	Kindler Jeffrey B71	Director	Sell	174,360	$3.47	$604,191.86	-17.9%	+35.3%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC